A hyphema is a collection of blood inside the front chamber of your eye, the fluid-filled space between your cornea and your iris. It typically appears as a visible layer of red blood pooling at the bottom of the iris and can range from a barely detectable scattering of blood cells to a complete filling of the chamber. Most hyphemas result from a direct blow to the eye, and while many resolve on their own within a week, the condition requires prompt evaluation to prevent complications like dangerously high eye pressure or vision loss.
What Happens Inside the Eye
Your eye’s front chamber (called the anterior chamber) is normally filled with a clear fluid that nourishes the eye and maintains its shape. When blood vessels in or around the iris tear, usually from blunt force, blood leaks into this space. Because blood is heavier than the surrounding fluid, it tends to settle at the bottom of the chamber, forming a visible red layer that you or someone else can often see without any special equipment.
That pooled blood creates problems beyond blocking your vision. The front chamber has a drainage system (the trabecular meshwork) that keeps fluid flowing out at a steady rate, maintaining healthy pressure inside the eye. Blood cells can clog this drainage, causing pressure to spike. If that pressure stays high, it can damage the optic nerve, the same mechanism behind glaucoma.
Causes of Hyphema
The vast majority of hyphemas are traumatic. A ball, fist, elbow, airbag deployment, or any blunt impact to the eye area can rupture the tiny blood vessels of the iris or the ciliary body behind it. Sports injuries and accidents are the most common culprits, and children and young adults are disproportionately affected.
Less commonly, hyphema can occur spontaneously. Conditions that make blood vessels fragile or promote abnormal vessel growth, such as diabetes, blood clotting disorders, or certain eye cancers, can cause bleeding without any trauma. Eye surgery can also lead to hyphema as a postoperative complication.
Symptoms and What It Looks Like
The hallmark sign is visible blood in the eye. In mild cases, the blood may appear as a faint reddish haze across the iris rather than a distinct layer. In more severe cases, you can see a clear horizontal line of blood sitting at the bottom of the colored part of the eye. A complete hyphema fills the entire front chamber, giving the eye a uniformly dark red appearance.
Along with the visible blood, you may notice blurred or hazy vision, eye pain, increased sensitivity to light, and a feeling of pressure in the eye. In very small hyphemas (sometimes called microhyphemas), you might not see the blood at all without magnification, but you would still have pain or blurred vision after an eye injury.
How Hyphemas Are Graded
Doctors classify hyphemas by how much of the front chamber is filled with blood, which helps guide treatment decisions and predict outcomes:
- Grade 0 (microhyphema): Scattered red blood cells visible under magnification but no layered blood.
- Grade I: Blood fills less than one-third of the chamber.
- Grade II: Blood fills one-third to one-half of the chamber.
- Grade III: Blood fills more than half but not all of the chamber.
- Grade IV: The entire chamber is filled with blood, sometimes called a “total” or “eight-ball” hyphema because the eye can appear completely dark.
Higher grades carry greater risk of complications and longer recovery times.
The Risk of Rebleeding
One of the biggest concerns after a hyphema is secondary hemorrhage, a second episode of bleeding that occurs days after the initial injury. This happens because the clot that forms over the torn blood vessels can break down before the vessels have fully healed. Rebleeding typically occurs within the first two to five days and tends to be worse than the original bleed.
Overall, secondary hemorrhage occurs in about 8% of hyphema cases. But certain factors raise that risk significantly. One study found that the rebleeding rate jumped from 5% in low-risk patients to 15% in those with at least one risk factor. Those risk factors include initial vision of 20/200 or worse, blood filling more than one-third of the chamber, elevated eye pressure at the first exam, and waiting more than a day after injury to get medical attention.
Sickle Cell Trait: A Critical Risk Factor
People who carry sickle cell trait (not just sickle cell disease) face a uniquely elevated risk when they develop a hyphema. The low-oxygen environment inside the front chamber of the eye can cause their red blood cells to sickle, or change shape, making them far more likely to clog the eye’s drainage system. This raises eye pressure more quickly and to higher levels than in other patients.
According to the CDC, people with sickle cell trait who experience a hyphema are significantly more likely to develop glaucoma as a complication. Some standard pressure-lowering eye medications can actually worsen sickling, so the treatment approach needs to be adjusted. If you know you carry sickle cell trait and experience any eye trauma, make sure your eye doctor is aware of your status, as it changes the treatment plan in important ways.
How Hyphema Is Treated
Most hyphemas are self-limited, meaning the blood reabsorbs on its own. Treatment focuses on creating the right conditions for healing and preventing rebleeding. The standard approach includes resting with your head elevated at least 30 degrees (sleeping propped up on pillows, not lying flat). This angle lets gravity pull the blood to the bottom of the chamber, clearing your line of sight and keeping blood cells away from the drainage area.
You’ll typically be asked to wear a rigid eye shield to protect against any accidental bumps, and to limit physical activity. Bending, lifting, and straining can all increase pressure in the eye or dislodge the healing clot. Strict bed rest is recommended for higher-risk patients, including those with sickle cell disease, clotting disorders, or severe hyphemas.
Medications that thin the blood or prevent clotting, including aspirin and common over-the-counter anti-inflammatory painkillers, need to be stopped because they increase bleeding risk. Your doctor will typically prescribe anti-inflammatory eye drops to reduce swelling and prevent scarring inside the eye, along with drops that relax the muscles inside the eye, reducing pain from spasms. In some cases, medications that stabilize blood clots are used to lower the chance of rebleeding. If eye pressure rises, pressure-lowering drops are added.
When Surgery Is Needed
Surgery becomes necessary when the blood won’t clear on its own or when complications develop that threaten vision. Persistently high eye pressure that doesn’t respond to drops, a total (grade IV) hyphema that isn’t improving, or blood staining of the cornea are all reasons a surgeon may need to wash the blood out of the front chamber. The threshold for surgical intervention is lower in patients with sickle cell trait because their eyes tolerate elevated pressure poorly.
Recovery Timeline
Small hyphemas often clear within a week. Larger ones can take considerably longer. According to the American Academy of Ophthalmology, a hyphema can take several months to fully clear from the front of the eye, with the timeline directly related to the volume of blood involved.
If the blood lingers long enough to stain the cornea (the clear front surface of the eye), recovery becomes more complicated. Corneal blood staining can persist even after the blood in the chamber is gone, and in severe cases may require a corneal transplant to restore clarity. Doctors typically observe corneal staining for at least six months before considering surgery, since some staining resolves on its own given enough time.
Follow-up visits are frequent in the first week, when rebleeding risk is highest, then spaced out over weeks to months. Long-term monitoring for glaucoma is important even after the blood clears, because damage to the eye’s drainage structures from the initial injury can cause pressure problems months or years later.